Skip to main content
Ocumension Therapeutics logo

Ocumension Therapeutics — Investor Relations & Filings

Ticker · 1477 ISIN · KYG674111011 LEI · 5493000USURI3SIL4Z85 HKEX Manufacturing
Open in API
Filings indexed 459 across all filing types
Latest filing 2025-02-12 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 1477

About Ocumension Therapeutics

http://www.ocumension.com

Ocumension Therapeutics is an ophthalmic pharmaceutical platform company dedicated to the research, development, and commercialization of first-in-class or best-in-class therapeutics. The company focuses on providing comprehensive treatment solutions for Chinese patients suffering from ocular diseases. Ocumension has established a complete ophthalmic drug product line, currently holding 20 drug assets covering both anterior and posterior segments of the eye. Its portfolio addresses major conditions such as chronic non-infectious uveitis, infective and allergic conjunctivitis, and diabetic macular edema. The company employs a strategy combining continuous scientific innovation, independent R&D, and strategic alliances to sustain the supply of innovative products across the ophthalmology field.

Recent filings

Filing Released Lang Actions
VOLUNTARY ANNOUNCEMENT UNAUDITED OPERATING DATA FOR THE YEAR ENDED DECEMBER 31, 2024
Regulatory Filings Classification · 77% confidence The document is a voluntary announcement on HKEx containing preliminary, unaudited operating data (year‐end revenue range and business highlights) rather than a full or interim financial report. It is not an Annual Report (10-K), Interim Report (IR), Earnings Release (ER) of finalized results, or any of the other specific categories (e.g., board changes, M&A, dividends). This type of miscellaneous regulatory disclosure on preliminary operating data best fits the fallback category for miscellaneous regulatory announcements: Regulatory Filings (RNS).
2025-02-12 English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 January 2025
Regulatory Filings Classification · 82% confidence The document is a standard HKEX FF301 form titled “Monthly Return for Equity Issuer…on Movements in Securities,” providing a mandatory regulatory return on share capital changes (authorized, issued, treasury shares, options, warrants, buy-backs) under the Exchange Listing Rules. It is neither a financial report (10-K, IR) nor a single corporate action announcement (SHA/POS) but a recurring listing rule compliance filing. It does not fit any specific report category, so it falls under the general regulatory filings fallback category.
2025-02-05 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 92% confidence The document is a Hong Kong Stock Exchange Next Day Disclosure Return (Form FF305) detailing changes in issued shares, treasury share buybacks, and on-market sale of treasury shares, including repurchase prices, aggregate amounts, and mandate details. This corresponds exactly to a report of the company buying back or selling its own shares, fitting the definition of Transaction in Own Shares (Code: POS).
2025-01-28 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 90% confidence The document is a Hong Kong Stock Exchange Form FF305 Next Day Disclosure Return detailing changes in issued shares and repurchase of treasury shares, including specific trading dates, numbers repurchased, prices paid and confirmation of compliance with listing rules. This is a direct report on the company’s own share transactions (buybacks and treasury share sales). According to the classification definitions, this corresponds to Transaction in Own Shares (code: POS).
2025-01-27 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 92% confidence The document is a Next Day Disclosure Return (Form FF305) required under the Hong Kong Stock Exchange listing rules, detailing changes in issued shares and treasury shares, including a share repurchase. This is a report of the company buying back its own shares. Hence it fits the “Transaction in Own Shares” category (Code: POS).
2025-01-24 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 89% confidence The document is a ‘Next Day Disclosure Return’ under Hong Kong Listing Rules detailing changes in issued shares and treasury shares, including a company share repurchase (404,500 shares) and on-market sale of treasury shares. It provides a full breakdown of the repurchase report (Section II) and confirmation under the Main Board/GEM rules. This is precisely a report of the company buying back its own shares, matching the “Transaction in Own Shares” category.
2025-01-23 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.